Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01079195
What this trial is testing

Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes Mellitus

Who this might be right for
Hypertension
Abbott 15,436
Testing effectiveness (Phase 2)Study completedNCT00528645
What this trial is testing

AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerLung MetastasesMalignant Pleural Effusion+1 more
National Cancer Institute (NCI) 23
Not applicableWithdrawnNCT06434714
What this trial is testing

Management of Postoperative Pain After Cesarean Delivery Using Bridge Auricular Percutaneous Nerve Field Stimulator

Who this might be right for
Post-operative Pain, AcuteCesarean SectionOpioid Use Disorder+1 more
Inova Health Care Services
Large-scale testing (Phase 3)UnknownNCT00610636
What this trial is testing

Treatment Outcomes of Hepatic Metastasis After FOLFOX-4 Therapy

Who this might be right for
Colorectal Cancer
National Taiwan University Hospital 200
Testing effectiveness (Phase 2)Study completedNCT03043599
What this trial is testing

Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerExtensive-stage Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 21
Not applicableStudy completedNCT02023814
What this trial is testing

Peripheral Blood CD34-positive Cells Enumeration as Predictor of Stem Cell Harvest

Who this might be right for
Blood Stem Cell Harvest Failure
Ospedale Santa Croce-Carle Cuneo 250
Post-approval studies (Phase 4)Not Yet RecruitingNCT06564714
What this trial is testing

Early Pharmacological Treatment of Acute Spasticity After Spinal Cord Injury

Who this might be right for
Traumatic Spinal Cord Injury
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 55
Not applicableUnknownNCT05546619
What this trial is testing

Research on Effectiveness and Safety of the Treatment, Hyperthermic Intraperitoneal Chemotherapy Combined With Tislelizumab and Targeted Therapy, That is Used for High-risk Hepatocellular Carcinoma After R0 Resection

Who this might be right for
Hepatocellular Carcinoma
Sulai Liu 30
Testing effectiveness (Phase 2)Ended earlyNCT00510471
What this trial is testing

Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Genitope Corporation
Large-scale testing (Phase 3)Looking for participantsNCT05871099
What this trial is testing

Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not

Who this might be right for
Gastric Cancer
The Affiliated Hospital of Qingdao University 616
Testing effectiveness (Phase 2)Looking for participantsNCT07506057
What this trial is testing

Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard Therapy

Who this might be right for
Urothelial CarcinomaBiliary Tract CancerHER2
Xiujuan Qu 20
Testing effectiveness (Phase 2)WithdrawnNCT03834571
What this trial is testing

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+4 more
AIDS Malignancy Consortium
Testing effectiveness (Phase 2)UnknownNCT04146181
What this trial is testing

Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sinocelltech Ltd. 103
Not applicableAvailableNCT07601399
What this trial is testing

An EAP Treatment Protocol of Zipalertinib

Who this might be right for
Non-Small Cell Lung Cancer
Taiho Oncology, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07181499
What this trial is testing

Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI

Who this might be right for
NSCLCAdjuvant Drug TherapyEGFR
Betta Pharmaceuticals Co., Ltd. 28
Not applicableActive Not RecruitingNCT07407244
What this trial is testing

Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer

Who this might be right for
Breast Cancer
Institute of Oncology Ljubljana 268
Not applicableLooking for participantsNCT06493734
What this trial is testing

Stereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma

Who this might be right for
Klatskin Tumor
Erasmus Medical Center 30
Large-scale testing (Phase 3)Looking for participantsNCT07413809
What this trial is testing

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

Who this might be right for
Multiple Myeloma
The Affiliated People's Hospital of Ningbo University 92
Testing effectiveness (Phase 2)Study completedNCT00392171
What this trial is testing

The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)

Who this might be right for
GliomaAstrocytomaOligodendroglioma+1 more
Merck Sharp & Dohme LLC 120
Large-scale testing (Phase 3)Ended earlyNCT05239663
What this trial is testing

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Who this might be right for
Chemotherapy-Related Cognitive ImpairmentBreast Cancer
Sun Yat-sen University 76
Next Page